Skip to content

Washington, D.C. · Nonprofit

ASN Foundation for Kidney Research

ASN Foundation for Kidney Research (Washington, D.C.) receives grants from 8 organizations whose IRS filings report $537,995 to it, the largest being The Oxalosis & Hyperoxaluria Foundation ($250,000). 6 of them have funded it in more than one year.

Revenue FY2025
$7.4M
Funders on record
8
Grants received
$538k
Net assets
$69M
6/8 repeat funderspeak grant-dependency 4%
01What it does

What ASN Foundation for Kidney Research does

Mission

To prevent and cure kidney diseases through research and innovation.

As stated on its FY2025 Form 990.

Programs

On its FY2025 return the organization reported starting a significant new program.

William and Sandra Bennett Clinical Scholars Program: The goal of the William and Sandra Bennett Clinical Scholars Program is to produce the next generation of clinician educators by supporting aspiring nephrology educators to conduct a project to advance all facets of nephrology education and teaching.

Its own explanation, from Schedule O of that return (Part III, line 2).

  1. Transistion to Independence Grants (formerly Career Development Grants):The KidneyCure Transition to Independence Grants Program provides funding for young faculty to foster evolution to an independent research career and a successful, competitive application for a National Institutes of Health (NIH) R01 grant or equivalent.

    $2,350,000 spentof which $2,350,000 as grants
    75% of program spending
  2. Research Fellowship Program: The goal of the Ben J. Lipps Research Fellowship Program is to fund nephrology fellows to conduct original, meritorious research projects. This program will foster the training of fellows, under the direction of a sponsor, who are highly motivated to make contributions to the understanding of kidney biology and disease. This Fellowship serves to establish the beginnings of an independent career.

    $473,639 spentof which $473,639 as grants
    15% of program spending
  3. Harold Amos Medical Faculty Development Program: The American Society of Nephrology-Harold Amos Medical Faculty Development Program (ASN-AMFDP) Award aims to increase diversity among future leaders in nephrology by supporting the research and career development of a kidney scholar and future health care leader from a historically disadvantaged background.

    $210,000 spentof which $210,000 as grants
    7% of program spending
  4. William and Sandra Bennett Clinical Scholars Program: The goal of the William and Sandra Bennett Clinical Scholars Program is to produce the next generation of clinician educators by supporting aspiring nephrology educators to conduct a project to advance all facets of nephrology education and teaching.

    $100,000 spentof which $100,000 as grants
    3% of program spending

The 4 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $3,133,639.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($19M) Expenses 100 ($2.9M) Net assets 100 ($49M)2018 Revenue 11 ($2.1M) Expenses 95 ($2.8M) Net assets 89 ($44M)2019 Revenue 17 ($3.2M) Expenses 92 ($2.7M) Net assets 104 ($51M)2020 Revenue 9 ($1.6M) Expenses 95 ($2.8M) Net assets 113 ($56M)2021 Revenue 45 ($8.3M) Expenses 105 ($3.1M) Net assets 122 ($60M)2022 Revenue 15 ($2.7M) Expenses 96 ($2.8M) Net assets 102 ($50M)2023 Revenue 15 ($2.9M) Expenses 97 ($2.8M) Net assets 111 ($55M)2024 Revenue 77 ($14M) Expenses 105 ($3.1M) Net assets 120 ($59M)2025 Revenue 40 ($7.4M) Expenses 109 ($3.2M) Net assets 139 ($69M)
'17'18'19'20'21'22'23'24'25
Revenue (40)Expenses (109)Net assets (139)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $60M to $50M (−16%).

$49M
$44M
$51M
$56M
$60M
$50M
$56M
$59M
$69M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

59% of ASN Foundation for Kidney Research’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).

This organization
Typical peer · 8,632 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 9 reported years ran a deficit.

$16M
’17
−$689k
’18
$519k
’19
−$1.2M
’20
$5.2M
’21
−$92k
’22
$30k
’23
$11M
’24
$4.2M
’25
3.2
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Deidra C Crews MD MS FASN

Board Chair

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed888989978
Joined·+1+2+4+1+1+1+0+2
No longer listed·12320121
03Who funds it

Who funds it, year by year

2017 → 2023: the base held at 3 funders, grant income fell $208k → $43k.

4 of 8 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 16% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $19M from one payer (the payer shares this organization's board, largest American Society of Nephrology). These are real filings, and they are not money ASN Foundation for Kidney Research raised.

From the IRS filings of ASN Foundation for Kidney Research’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

ASN Foundation for Kidney Research leans on a few funders — its largest provides 46% of grant income and the top three 81%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

79% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ASN Foundation for Kidney Research.

46%
largest funder
81%
top three
~3
effective funders

Largest funder’s share by year: 2017 48% · 2018 100% · 2019 88% · 2020 52% · 2021 86% · 2022 72% · 2023 81% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

29% of ASN Foundation for Kidney Research's funders are still giving 3 years after their first grant; 75% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

ASN Foundation for Kidney Research draws 100% of its grant income from funders outside Washington, D.C., across 4 states in all.

IL
NY
PA
FL

In-state vs out-of-state, by year

’17
’19
’20
’21
’22
’23
Washington, D.C. out of state home

Funder states come from each funder’s own filing. $87k arriving through sponsors registered in 4 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

ASN Foundation for Kidney Research runs a healthier operating margin than three-quarters of the 5,002 health nonprofits its size.

Operating margin57% · top quartile
Months of reserve3.2mo · below the median
Revenue growth (annualized)−11% · bottom quartile

this organization peer median middle 50% of peers· 5,002 health nonprofits $1M–$10M, FY2025

Organizations like ASN Foundation for Kidney Research

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Washington, D.C.

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

98% of spending goes to programs.

Program 98%Management 2%Fundraising 0%

Governance

9
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

52%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

DC

Part of a family of 1 related entity

  • American Society of Nephrology · exempt

Screen this organization

A dated, signed PDF of the compliance screen for ASN Foundation for Kidney Research: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds ASN Foundation for Kidney Research?
ASN Foundation for Kidney Research (Washington, D.C.) receives grants from 8 organizations whose IRS filings report $537,995 to it, the largest being The Oxalosis & Hyperoxaluria Foundation ($250,000). 6 of them have funded it in more than one year.
How many funders does ASN Foundation for Kidney Research have?
IRS filings report 8 organizations giving $537,995 in grants to ASN Foundation for Kidney Research, 6 of which have funded it in more than one year.
Who is the largest funder of ASN Foundation for Kidney Research?
The Oxalosis & Hyperoxaluria Foundation is the largest funder on record, with $250,000 in grants. The full list of funders is on this page.
How can an organization like ASN Foundation for Kidney Research find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 8 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing